Evidence mapPaperPMID 36016137Full record

ArticleVaccines2022

Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.

Md Parvez Mosharaf, Md Kaderi Kibria, Md Bayazid Hossen, Md Ariful Islam, Md Selim Reza, Rashidul Alam Mahumud, Khorshed Alam, Jeff Gow, Md Nurul Haque Mollah

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Md Parvez MosharafBioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh.
Md Kaderi KibriaBioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh.
Md Bayazid HossenBioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh.ORCID 0000-0001-7634-2785
Md Ariful IslamBioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh.
Md Selim RezaBioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh.
Rashidul Alam MahumudNHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.
Khorshed AlamSchool of Business, Faculty of Business, Education, Law and Arts, University of Southern Queensland, Toowoomba, QLD 4350, Australia.ORCID 0000-0003-2232-0745
Jeff GowSchool of Business, Faculty of Business, Education, Law and Arts, University of Southern Queensland, Toowoomba, QLD 4350, Australia.
Md Nurul Haque MollahBioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh.ORCID 0000-0002-3883-3396
University of Rajshahi · BDUniversity of Southern Queensland · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pandemic of SARS-CoV-2 infections is a severe threat to human life and the world economic condition. Although vaccination has reduced the outspread, but still the situation is not under control because of the instability of RNA sequence patterns of SARS-CoV-2, which requires effective drugs. Several studies have suggested that the SARS-CoV-2 infection causing hub differentially expressed genes (Hub-DEGs). However, we observed that there was not any common hub gene (Hub-DEGs) in our analyses. Therefore, it may be difficult to take a common treatment plan against SARS-CoV-2 infections globally. The goal of this study was to examine if more representative Hub-DEGs from published studies by means of hub of Hub-DEGs (hHub-DEGs) and associated potential candidate drugs. In this study, we reviewed 41 articles on transcriptomic data analysis of SARS-CoV-2 and found 370 unique hub genes or studied genes in total. Then, we selected 14 more representative Hub-DEGs (

Indexed as

drug repurposingmolecular docking and dynamic simulationSARS-CoV-2 infectionsselection of drug targets and agents

Identifiers

PMID36016137
PMCPMC9415433
OpenAlexW4289731785

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.